🔗 Permalink

Inventor profile of:

Christoph ESSLINGER

City:

Zurich

Country:

Switzerland

Published Applications:

Last publication date:

2024-07-11

Top Assignees for applications by Christoph ESSLINGER

The entities that hold a legal rights for patent applications filed by inventor ESSLINGER Christoph:

UNIVERSITY OF ZURICH 15 Zurich, Switzerland
CT ATLANTIC LTD 3 Schlieren, Switzerland
Memo Therapeutics AG 3 Schlieren, Switzerland
UNIVERSITÄT ZÜRICH 1 Zürich, Switzerland
UNIVERSITY OF ZÜRICH 1 Zürich, Switzerland
UNIVERSITÄT BERN 1 Bern, Switzerland

Recent patent applications by ESSLINGER Christoph

Christoph ESSLINGER from Zurich, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-07-11

US20240228590A9

Chemistry; metallurgy

ANTI-BK VIRUS ANTIBODY MOLECULES

#2 | 2024-04-25

US20240132575A1

Chemistry; metallurgy

ANTI-BK VIRUS ANTIBODY MOLECULES

#3 | 2023-06-22

US20230192816A1

Chemistry; metallurgy

Anti-BK virus antibody molecules

#4 | 2023-01-12

US20230009582A1

Chemistry; metallurgy

ANTI-SIGLEC-9 ANTIBODY MOLECULES

#5 | 2022-12-22

US20220403011A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#6 | 2022-04-28

US20220127599A1

Chemistry; metallurgy

Method for recovering two or more genes, or gene products, encoding an immunoreceptor

#7 | 2019-08-29

US20190263896A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#8 | 2019-05-23

US20190153082A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#9 | 2018-12-13

US20180353603A1

Human necessities

Combination therapy including tumor associated antigen binding antibodies

#10 | 2018-05-17

US20180134773A1

Chemistry; metallurgy

Methods of treating Alzheimer's disease

#11 | 2017-10-05

US20170283491A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

#12 | 2017-02-16

US20170044523A1

Chemistry; metallurgy

Method for recovering two or more genes, or gene products, encoding an immunoreceptor

#13 | 2016-10-06

US20160289310A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

#14 | 2015-05-28

US20150147343A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#15 | 2014-07-03

US20140186363A1

Chemistry; metallurgy

MAGEA3 BINDING ANTIBODIES

#16 | 2014-04-03

US20140093514A1

Chemistry; metallurgy

MAGEA3 BINDING ANTIBODIES

#17 | 2013-11-07

US20130295091A1

Human necessities

COMBINATION THERAPY INCLUDING TUMOR ASSOCIATED ANTIGEN BINDING ANTIBODIES

#18 | 2013-10-10

US20130266586A1

Human necessities

Method of Providing Disease-Specific Binding Molecules and Targets

#19 | 2013-10-10

US20130266585A1

Chemistry; metallurgy

Method of Providing Disease-Specific Binding Molecules and Targets

#20 | 2013-10-10

US20130266514A1

Chemistry; metallurgy

Method of Providing Disease-Specific Binding Molecules and Targets

#21 | 2013-08-22

US20130216555A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

#22 | 2011-07-14

US20110171688A1

Chemistry; metallurgy

METHOD OF PROVIDING IMMUNOGLOBULIN SECRETING B LYMPHOCYTES AND HUMAN ANTIBODIES

#23 | 2011-05-26

US20110123447A1

Chemistry; metallurgy

METHOD OF PROVIDING HUMAN TUMOR-SPECIFIC ANTIBODIES

#24 | 2010-12-30

US20100330075A1

Chemistry; metallurgy

Monoclonal human tumor-specific antibody

#25 | 2010-08-12

US20100202968A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

InventorID:

401034 ⎘